US 9029338
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
granted A61KA61K47/22A61K48/0075
Quick answer
US patent 9029338 (Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus) held by Alnylam Pharmaceuticals, Inc. expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K47/22, A61K48/0075, A61P, A61P31/14